Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Wuchner

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Small (Weinheim an Der Bergstrasse, Germany)|August 23, 2024
Real-Time Observation of Protein Aggregation at Liquid-Liquid Interfaces in a Microfluidic DeviceDominik Zürcher, Klaus Wuchner, Paolo Arosio
Molecular Pharmaceutics|October 24, 2024
Mitigation Strategies against Antibody Aggregation Induced by Oleic Acid in Liquid FormulationsDominik Zürcher, Klaus Wuchner, Paolo Arosio
Pharmaceutics|April 16, 2014
Analytical challenges and regulatory requirements for nasal drug products in europe and the u.sSabrina Trows, Klaus Wuchner, Rene Spycher, et al.
Journal of Pharmaceutical Sciences|January 15, 2019
Factors Influencing Polysorbate's Sensitivity Against Enzymatic Hydrolysis and Oxidative DegradationWendelin Kranz, Klaus Wuchner, Eleonora Corradini, et al.
Journal of Pharmaceutical Sciences|July 13, 2020
Micelle Driven Oxidation Mechansim and Novel Oxidation Markers for Different Grades of Polysorbate 20 and 80Wendelin Kranz, Klaus Wuchner, Eleonora Corradini, et al.
Journal of Pharmaceutical Sciences|July 15, 2024
A comparison of Polysorbates and Alternative Surfactants for Interfacial Stress Protection and Mitigation of Fatty Acid Particle Formation in the Presence of an EsteraseIan Roy, Klaus Wuchner, Patrick Stahl, et al.
Journal of Pharmaceutical Sciences|March 16, 2010
Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulationKlaus Wuchner, Jochen Büchler, Rene Spycher, et al.
Journal of Pharmaceutical Sciences|March 28, 2019
Backgrounded Membrane Imaging (BMI) for High-Throughput Characterization of Subvisible Particles During Biopharmaceutical Drug Product DevelopmentConstanze Helbig, Gregor Ammann, Tim Menzen, et al.
Journal of Pharmaceutical Sciences|June 6, 2022
Combining Machine Learning and Backgrounded Membrane Imaging: A Case Study in Comparing and Classifying Different Types of Biopharmaceutically Relevant ParticlesChristopher P Calderon, Ana Krhač Levačić, Constanze Helbig, et al.
Journal of Pharmaceutical Sciences|June 9, 2023
Comparison of the Protective Effect of Polysorbates, Poloxamer and Brij on Antibody Stability Against Different InterfacesDominik Zürcher, Severin Caduff, Laetitia Aurand, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Small (Weinheim an Der Bergstrasse, Germany)|August 23, 2024
Real-Time Observation of Protein Aggregation at Liquid-Liquid Interfaces in a Microfluidic DeviceDominik Zürcher, Klaus Wuchner, Paolo Arosio
Molecular Pharmaceutics|October 24, 2024
Mitigation Strategies against Antibody Aggregation Induced by Oleic Acid in Liquid FormulationsDominik Zürcher, Klaus Wuchner, Paolo Arosio
Pharmaceutics|April 16, 2014
Analytical challenges and regulatory requirements for nasal drug products in europe and the u.sSabrina Trows, Klaus Wuchner, Rene Spycher, et al.
Journal of Pharmaceutical Sciences|January 15, 2019
Factors Influencing Polysorbate's Sensitivity Against Enzymatic Hydrolysis and Oxidative DegradationWendelin Kranz, Klaus Wuchner, Eleonora Corradini, et al.
Journal of Pharmaceutical Sciences|July 13, 2020
Micelle Driven Oxidation Mechansim and Novel Oxidation Markers for Different Grades of Polysorbate 20 and 80Wendelin Kranz, Klaus Wuchner, Eleonora Corradini, et al.
Journal of Pharmaceutical Sciences|July 15, 2024
A comparison of Polysorbates and Alternative Surfactants for Interfacial Stress Protection and Mitigation of Fatty Acid Particle Formation in the Presence of an EsteraseIan Roy, Klaus Wuchner, Patrick Stahl, et al.
Journal of Pharmaceutical Sciences|March 16, 2010
Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulationKlaus Wuchner, Jochen Büchler, Rene Spycher, et al.
Journal of Pharmaceutical Sciences|March 28, 2019
Backgrounded Membrane Imaging (BMI) for High-Throughput Characterization of Subvisible Particles During Biopharmaceutical Drug Product DevelopmentConstanze Helbig, Gregor Ammann, Tim Menzen, et al.
Journal of Pharmaceutical Sciences|June 6, 2022
Combining Machine Learning and Backgrounded Membrane Imaging: A Case Study in Comparing and Classifying Different Types of Biopharmaceutically Relevant ParticlesChristopher P Calderon, Ana Krhač Levačić, Constanze Helbig, et al.
Journal of Pharmaceutical Sciences|June 9, 2023
Comparison of the Protective Effect of Polysorbates, Poloxamer and Brij on Antibody Stability Against Different InterfacesDominik Zürcher, Severin Caduff, Laetitia Aurand, et al.
Pageof 4